OPPS Drug Acquisition Cost Survey Description and Burden Calculation From January 1, 2026, through March 31, 2026, we intend to survey hospitals paid under the OPPS for their drug acquisition costs, including for SCODs, and drugs and biologicals CMS historically treats as SCODs
The measure is not risk-adjusted because the numerator events are considered access failures regardless of ( patient acuity or clinical comorbidity
The following data is based on the product molecular weight 1,419.56 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions
human clinical trials are ongoing as of 2026
BPC-157 is a synthetic 15-amino-acid peptide derived from a protective protein in human gastric juice
Using a straightforward, efficient method, the nutrients are delivered directly into your bloodstream, ensuring maximum absorption